Skip to main content
User menu
Cart
Login
DIAL.pr - BOREAL
Search form
Search
Home
All Publications
Export
Help
Current search
Mandelli, F.
Kunzmann, R
Author
2
Lubbert, M
Apply Lubbert, M filter
1
Haak, H
Apply Haak, H filter
1
Luebbert, M
Apply Luebbert, M filter
Date
1
2000
Apply 2000 filter
1
1999
Apply 1999 filter
1
1998
Apply 1998 filter
Document Type
2
Communication à un colloque (Conference Paper)
Apply Communication à un colloque (Conference Paper) filter
1
Article de périodique (Journal article)
Apply Article de périodique (Journal article) filter
You are here
Home
»
Search
»
Search results
»
sm_creator:"Wijermans, P"
»
^Mandelli, F.
»
^Kunzmann, R
»
Search
Accès à distance ? S'identifier sur le proxy
UCLouvain
Search
Sort by
Relevancy
Publication date desc
Publication date asc
Creation date
Fulltext
Displaying
3
results.
Speech
A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients.
Wijermans, P
Ferrant, Augustin
[UCL]
Lubbert, M
Verhoef, G.
Bosly, André
[UCL]
Ravoet, C
André, Marc
(1998)
—
Speech
DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).
Wijermans, P
Ferrant, Augustin
[UCL]
Luebbert, M
Verhoef, G.
Bosly, André
[UCL]
Ravoet, C
André, Marc
Haak, H
(1999)
—
Journal article
Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
Wijermans, P
Ferrant, Augustin
[UCL]
Lubbert, M
Verhoef, G.
Bosly, André
[UCL]
Ravoet, C
André, Marc
(2000)
Journal of Clinical Oncology — Vol. 18, no. 5, p. 956-962 (2000)